Brokerages Set Clorox Co (NYSE:CLX) PT at $152.46

Clorox Co (NYSE:CLX) has earned an average recommendation of “Hold” from the fifteen brokerages that are currently covering the stock, Marketbeat reports. Three research analysts have rated the stock with a sell recommendation, ten have issued a hold recommendation and two have assigned a buy recommendation to the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $152.46.

Several equities research analysts recently commented on the stock. Argus lowered shares of Clorox from a “buy” rating to a “hold” rating in a report on Monday, May 20th. Royal Bank of Canada boosted their price target on shares of Clorox to $161.00 and gave the stock a “sector perform” rating in a report on Friday, August 2nd. BMO Capital Markets set a $168.00 price target on shares of Clorox and gave the stock a “buy” rating in a report on Thursday, May 2nd. UBS Group boosted their price target on shares of Clorox from $110.00 to $128.00 and gave the stock a “sell” rating in a report on Friday, August 2nd. Finally, ValuEngine lowered shares of Clorox from a “buy” rating to a “hold” rating in a report on Thursday, August 1st.

NYSE CLX traded down $1.29 on Wednesday, hitting $157.67. The company had a trading volume of 547,468 shares, compared to its average volume of 1,013,014. The stock has a market capitalization of $20.20 billion, a P/E ratio of 24.95, a PEG ratio of 4.98 and a beta of 0.37. The company’s fifty day moving average price is $158.44. The company has a quick ratio of 0.55, a current ratio of 0.91 and a debt-to-equity ratio of 4.09. Clorox has a 12-month low of $141.53 and a 12-month high of $167.70.



Clorox (NYSE:CLX) last issued its quarterly earnings results on Thursday, August 1st. The company reported $1.88 EPS for the quarter, topping the consensus estimate of $1.84 by $0.04. The company had revenue of $1.63 billion during the quarter, compared to analyst estimates of $1.69 billion. Clorox had a net margin of 13.20% and a return on equity of 118.88%. The firm’s revenue was down 3.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.66 EPS. As a group, equities research analysts predict that Clorox will post 6.4 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 16th. Stockholders of record on Wednesday, July 31st will be issued a dividend of $1.06 per share. This is a positive change from Clorox’s previous quarterly dividend of $0.96. The ex-dividend date is Tuesday, July 30th. This represents a $4.24 dividend on an annualized basis and a dividend yield of 2.69%. Clorox’s dividend payout ratio is presently 67.09%.

In other news, Director A D. David Mackay sold 3,400 shares of the company’s stock in a transaction on Tuesday, August 6th. The shares were sold at an average price of $154.87, for a total transaction of $526,558.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Diego J. Barral sold 1,987 shares of the company’s stock in a transaction on Friday, August 2nd. The stock was sold at an average price of $157.59, for a total transaction of $313,131.33. The disclosure for this sale can be found here. Insiders have sold 25,786 shares of company stock valued at $4,054,776 in the last ninety days. Insiders own 1.40% of the company’s stock.

Several hedge funds have recently made changes to their positions in CLX. Dimensional Fund Advisors LP boosted its position in shares of Clorox by 8.5% during the 4th quarter. Dimensional Fund Advisors LP now owns 582,745 shares of the company’s stock valued at $89,822,000 after acquiring an additional 45,408 shares during the last quarter. Geode Capital Management LLC boosted its position in shares of Clorox by 21.5% during the 4th quarter. Geode Capital Management LLC now owns 1,899,544 shares of the company’s stock valued at $292,347,000 after acquiring an additional 335,835 shares during the last quarter. Two Sigma Advisers LP acquired a new position in shares of Clorox during the 4th quarter valued at about $355,000. Thrivent Financial for Lutherans boosted its position in shares of Clorox by 1.8% during the 4th quarter. Thrivent Financial for Lutherans now owns 5,660 shares of the company’s stock valued at $872,000 after acquiring an additional 99 shares during the last quarter. Finally, Millennium Management LLC boosted its position in shares of Clorox by 323.7% during the 4th quarter. Millennium Management LLC now owns 6,643 shares of the company’s stock valued at $1,024,000 after acquiring an additional 9,613 shares during the last quarter. 77.01% of the stock is currently owned by hedge funds and other institutional investors.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Featured Story: How is inflation measured?

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.